ZESTRON America celebrates opening of new technical facility

ZESTRON America celebrated on May 11, 2007 the official opening of its new US headquarters in Manassas. Domestic and international representatives ranging from elected officials and industry partners contributed to the success of this event.

Zestron's founder and President, Dr. Oskar K. Wack was on hand at the event to share his years of experience.

He talked of how the banning of CFCs in the 1980s spurred his belief in this new opportunity and that while others chased a single replacement, he understood that no single replacement would work and that multiple chemistries would be needed.

When asked how Zestron compare to their competitors, he cited this new technical center as an example, they are the only company in their field with technology centers in the US, Europe and Asia. This strong commitment to engineering support is a key differentiator.

Dr. Wack believes that Zestron will continue to grow. They have been doubling their turnover every seven years and expect to better that in coming years. With growth into other areas beyond electronics, such as medical products and metal cleaning, Zestron plans to increase its global leadership.

The people at Zestron are a key element to the service they provide. All engineers have chemistry degrees and receive at least a full year on in-house training before working with Zestron's growing customer base.

Neutrality is also key to Zestron. Working with all manufacturers of pastes, solders and of course equipment allows them to come up with the right solution. They have an impressive array of equipment at all of their technical centers.

Zestron is a company of more than 120 people and they aim to solve any existing customer technical issue within three hours.



The new 36,000 sqft building is the result of a lot of effort and an investment of more than $6M. But that is not the end of it. They have also purchased the land next door for future expansion. 

"Completing this building is a dream come true," said Dr. Oskar K. Wack.